BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menendez JA, Lupu R. Fatty acid synthase: A druggable driver of breast cancer brain metastasis. Expert Opin Ther Targets 2022. [PMID: 35545806 DOI: 10.1080/14728222.2022.2077189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Polonio-alcalá E, Porta R, Ruiz-martínez S, Vásquez-dongo C, Relat J, Bosch-barrera J, Ciurana J, Puig T. AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models. Biomedicine & Pharmacotherapy 2022;156:113942. [DOI: 10.1016/j.biopha.2022.113942] [Reference Citation Analysis]
2 Chu Q, Liu P, Song Y, Yang R, An J, Zhai X, Niu J, Yang C, Li B. Stearate‐derived very long‐chain fatty acids are indispensable to tumor growth. The EMBO Journal 2022. [DOI: 10.15252/embj.2022111268] [Reference Citation Analysis]
3 Meijuan C, Fang L, Min F, Qian W. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer. Int J Biochem Cell Biol 2022;:106274. [PMID: 35917927 DOI: 10.1016/j.biocel.2022.106274] [Reference Citation Analysis]